Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease

Pediatric Research

Volumn 71, Issue 6, 2012, Pages 720-724

  Gong, Fangqi ^a   Zhang, Ye ^a   Xie, Chunhong ^a   Zhu, Weihua ^a   Wang, Wei ^a   Fu, Songling ^a   Shen, Hongqiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN;

ACUTE DISEASE; ARTICLE; CELL SURFACE; CHILD; CIRCULATING ENDOTHELIUM CELL; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE; UPREGULATION;

CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DISEASE RESISTANCE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTORS, IMMUNOLOGIC; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84861403627     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.27     Document Type: Article

References (33)

1. Cuttica RJ. Vasculitis, Kawasaki disease, and pseudovasculitis. Curr Opin Rheumatol 1997;9:448-57. (Pubitemid 27437944)
2. Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1998;11:405-14. (Pubitemid 28379091)
3. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-82.
4. Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 1994;74:822-4. (Pubitemid 24312982)
5. Fujiwara T, Fujiwara H, Nakano H. Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis. Circulation 1988;78:345-50.
6. Fulton DR, Newburger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2000;2:324-9.
7. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. (Pubitemid 26307269)
8. Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki syndrome. Arthritis Rheum 1998;41:1538-47. (Pubitemid 28459911)
9. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: existence of cardiac sequelae elevated the mortality. J Epidemiol 2000;10:372-5.
10. Newburger JW, Takahashi M, Gerber MA, et al.; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71. (Pubitemid 39453026)
11. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005;67:1078-83. (Pubitemid 41623333)
12. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003;131:536-40. (Pubitemid 36324146)
13. Miranda LP, Tao T, Jones A, et al. Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE). FEBS Lett 2001;488:85-90. (Pubitemid 32332812)
14. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762-71. (Pubitemid 39643922)
15. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81:28-37. (Pubitemid 46021248)
16. Moroz OV, Antson AA, Dodson EJ, et al. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr D Biol Crystallogr 2002;58(Pt 3):407-13. (Pubitemid 34248850)
17. Roth J, Vogl T, Sorg C, Sunderkötter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003;24:155-8. (Pubitemid 36412096)
18. Rouleau P, Vandal K, Ryckman C, et al. The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clin Immunol 2003;107:46-54. (Pubitemid 36539445)
19. Moroz OV, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB. Multiple structural states of S100A12: A key to its functional diversity. Microsc Res Tech 2003;60:581-92.
20. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-55. (Pubitemid 32946067)
21. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901. (Pubitemid 29375048)
22. Xie J, Burz DS, He W, Bronstein IB, Lednev I, Shekhtman A. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 2007;282:4218-31. (Pubitemid 47084493)
23. Burns JC. S100 proteins in the pathogenesis of Kawasaki disease. J Am Coll Cardiol 2006;48:1265-7.
24. Ebihara T, Endo R, Kikuta H, et al. Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease. Eur J Pediatr 2005;164:427-31. (Pubitemid 40933208)
25. Foell D, Ichida F, Vogl T, et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 2003;361:1270-2. (Pubitemid 36428584)
26. Ye F, Foell D, Hirono KI, et al. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004;94:840-4. (Pubitemid 39221519)
27. Fu S, Gong F, Xie C, et al. S100A12 on circulating endothelial cells surface in children with Kawasaki disease. Pediatr Res 2010;68:165-8.
28. Taguchi A, Blood DC, del Toro G, et al. Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nat Lond 2000;405:354-60. (Pubitemid 30337069)
29. Mahajan N, Bahl A, Dhawan V. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin. Int J Cardiol 2010;142:273-8.
30. Zhong Y, Li SH, Liu SM, et al. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 2006;48:504-11. (Pubitemid 44253747)
31. Ayusawa M, Sonobe T, Uemura S, et al.; Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4. (Pubitemid 40545436)
32. Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 2010;31:242-9.
33. Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005;64:1-8. (Pubitemid 40960406)